Advanced Biomed (ADVB) Other Non-Current Liabilities (2025)

Advanced Biomed (ADVB) posted Other Non-Current Liabilities of $114065.0 for Q4 2025, down 40.27% sequentially from $190959.0 in Q3 2025.

Advanced Biomed (ADVB) Other Non-Current Liabilities (2025) Analysis & Trends

Advanced Biomed has reported Other Non-Current Liabilities for 1 years, with the latest figure at $114065.0 in Q4 2025.

Quarterly Other Non-Current Liabilities changed N/A year-over-year to $114065.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $114065.0 (changed N/A YoY) and the FY2025 annual result came in at $69975.0, changed N/A from the prior year.
Other Non-Current Liabilities eased to $114065.0 in Q4 2025 per ADVB's latest filing, from $190959.0 in the prior quarter.
Over five years, Other Non-Current Liabilities peaked at $190959.0 in Q3 2025 and troughed at $69975.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn
10	Advanced Biomed	10.46 Mn	10.46 Mn	-

Download Data